1
|
Kuntic M, Kuntic I, Cleppien D, Pozzer A, Nußbaum D, Oelze M, Junglas T, Strohm L, Ubbens H, Daub S, Bayo Jimenez MT, Danckwardt S, Berkemeier T, Hahad O, Kohl M, Steven S, Stroh A, Lelieveld J, Münzel T, Daiber A. Differential inflammation, oxidative stress and cardiovascular damage markers of nano- and micro-particle exposure in mice: Implications for human disease burden. Redox Biol 2025; 83:103644. [PMID: 40319735 PMCID: PMC12124686 DOI: 10.1016/j.redox.2025.103644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2025] [Revised: 04/17/2025] [Accepted: 04/17/2025] [Indexed: 05/07/2025] Open
Abstract
Particulate matter (PM) poses a significant risk to human health; however, it remains uncertain which size fraction is especially harmful and what mechanisms are involved. We investigated the varying effects of particle size on specific organ systems using a custom mouse exposure system and synthetic PM (SPM). Whole-body exposure of mice showed that micrometer-sized fine SPM (2-4 μm) accumulated in the lungs, the primary entry organ, while nanometer-sized SPM (<250 nm) did not accumulate, suggesting a transition into circulation. Mice exposed to micro-SPM exhibited inflammation and NADPH oxidase-derived oxidative stress in the lungs. In contrast, nano-SPM-exposed mice did not display oxidative stress in the lungs but rather at the brain, heart, and vascular levels, supporting the hypothesis that they penetrate the lungs and reach the circulation. Sources of reactive oxygen species from micro-SPM in the lung are NOX1 and NOX2, driven by pulmonary inflammation, while oxidative stress from nano-SPM in the heart is mediated by protein kinase C-dependent p47phox phosphorylation, leading to NOX2 activation in infiltrated monocytes. Endothelial dysfunction and increased blood pressure were more pronounced in nano-SPM-exposed mice, also supported by elevated endothelin-1 and reduced endothelial nitric oxide synthase expression, which enhances constriction and diminishes vasodilation. Further, we estimated the cardiovascular disease burden of nano-particles in humans based on global exposure data and hazard ratios from an epidemiological cohort study. These results provide novel insights into the disease burdens of inhaled nano- and micro-particles (corresponding to fine and ultrafine categories), guiding future studies.
Collapse
Affiliation(s)
- Marin Kuntic
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany
| | - Ivana Kuntic
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | - Dirk Cleppien
- Leibniz Institute for Resilience Research, Mainz, Germany
| | - Andrea Pozzer
- Max Planck Institute for Chemistry, Atmospheric Chemistry Department, Mainz, Germany
| | - David Nußbaum
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | - Matthias Oelze
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | - Tristan Junglas
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | - Lea Strohm
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | - Henning Ubbens
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | - Steffen Daub
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany
| | | | - Sven Danckwardt
- German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; University Medical Center Ulm, Department of Clinical Chemistry, Ulm, Germany
| | - Thomas Berkemeier
- Max Planck Institute for Chemistry, Multiphase Chemistry Department, Mainz, Germany
| | - Omar Hahad
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany
| | - Matthias Kohl
- Max Planck Institute for Chemistry, Atmospheric Chemistry Department, Mainz, Germany
| | - Sebastian Steven
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany; Division of Cardiology, Goethe University Frankfurt, University Hospital, Department of Medicine III, Frankfurt a. M., Germany
| | - Albrecht Stroh
- Leibniz Institute for Resilience Research, Mainz, Germany; University Medical Center Mainz, Institute of Pathophysiology, Mainz, Germany; Institute of Physiology I, University Hospital Muenster, Germany
| | - Jos Lelieveld
- Max Planck Institute for Chemistry, Atmospheric Chemistry Department, Mainz, Germany
| | - Thomas Münzel
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany
| | - Andreas Daiber
- University Medical Center Mainz, Department for Cardiology 1, Molecular Cardiology, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
| |
Collapse
|
2
|
Jaikang C, Konguthaithip G, Amornlertwatana Y, Autsavapromporn N, Rattanachitthawat S, Liampongsabuddhi N, Monum T. Metabolic Disruptions and Non-Communicable Disease Risks Associated with Long-Term Particulate Matter Exposure in Northern Thailand: An NMR-Based Metabolomics Study. Biomedicines 2025; 13:742. [PMID: 40149718 PMCID: PMC11940625 DOI: 10.3390/biomedicines13030742] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2025] [Revised: 03/14/2025] [Accepted: 03/14/2025] [Indexed: 03/29/2025] Open
Abstract
Background/Objectives: Particulate matter (PM) is a primary health hazard associated with metabolic pathway disruption. Population characteristics, topography, sources, and PM components contribute to health impacts. Methods: In this study, NMR-based metabolomics was used to evaluate the health impacts of prolonged exposure to PM. Blood samples (n = 197) were collected from healthy volunteers in low- (control; CG) and high-exposure areas (exposure; EG) in Northern Thailand. Non-targeted metabolite analysis was performed using proton nuclear magnetic resonance spectroscopy (1H-NMR). Results: Compared to CG, EG showed significantly increased levels of dopamine, N6-methyladenosine, 3-hydroxyproline, 5-carboxylcytosine, and cytidine (p < 0.05), while biopterin, adenosine, L-Histidine, epinephrine, and norepinephrine were significantly higher in CG (p < 0.05). These metabolic disturbances suggest that chronic exposure to particulate matter (PM) impairs energy and amino acid metabolism while enhancing oxidative stress, potentially contributing to the onset of non-communicable diseases (NCDs) such as cancer and neurodegenerative conditions. Conclusions: This study highlighted the connection between sub-chronic PM2.5 exposure, metabolic disturbances, and an increased risk of non-communicable diseases (NCDs), stressing the critical need for effective PM2.5 reduction strategies in Northern Thailand.
Collapse
Affiliation(s)
- Churdsak Jaikang
- Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (C.J.); (G.K.); (Y.A.); (N.L.)
- Metabolomics Research Group for Forensic Medicine and Toxicology, Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Giatgong Konguthaithip
- Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (C.J.); (G.K.); (Y.A.); (N.L.)
- Metabolomics Research Group for Forensic Medicine and Toxicology, Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Yutti Amornlertwatana
- Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (C.J.); (G.K.); (Y.A.); (N.L.)
- Metabolomics Research Group for Forensic Medicine and Toxicology, Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Narongchai Autsavapromporn
- Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand;
| | | | - Nitip Liampongsabuddhi
- Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (C.J.); (G.K.); (Y.A.); (N.L.)
- Metabolomics Research Group for Forensic Medicine and Toxicology, Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Tawachai Monum
- Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (C.J.); (G.K.); (Y.A.); (N.L.)
| |
Collapse
|